Arterial invasion predicts early mortality in stage I non-small cell lung cancer.

Background. A retrospective study was performed to evaluate the association between arterial invasion and survival in patients with stage I non-small cell lung cancer. Methods. One hundred patients were identified who had undergone complete anatomic resection as definitive treatment for stage I non-small cell lung cancer. The tumors were reviewed for the presence or absence of arterial invasion. Five-year survival data were obtained for all patients. Results. The 100 patients had an overall 5-year survival of 61%. There were 64 stage IA patients with a 62% 5-year survival and 36 stage IB patients with a 58% 5-year survival. The 39 patients identified with arterial invasion had a 38% 5-year survival compared with a 73% 5-year survival in the 61 patients without arterial invasion (p < 0.001), with an unadjusted hazard ratio of 3.5 (p < 0.001). Multivariate analysis by stage IA versus IB and by size greater or less than 2 cm demonstrated hazard ratios of 3.5 and 4.0. respectively (p < 0.001). This difference was independent of demographic characteristics, tumor type, or grade. Subgroup analysis revealed a hazard ratio of 5.8 in patients with stage IA non-small cell lung cancer (p < 0.001) and 19.8 in patients with tumors less than or equal to5 2 cm (p = 0.006). Conclusions. Arterial invasion is present in a substantial percentage of patients with stage I non-small cell lung cancer and is adversely associated with survival. (C) 2004 by The Society of Thoracic Surgeons.